KODYS CAN CARDIAC AUTONOMIC NEUROPATHY ANALYSER PRODUCT DEMONSTRATION

KODYS CAN CARDIAC AUTONOMIC NEUROPATHY ANALYSER PRODUCT
This video gives the demonstration in
• Series of 6 tests to analyzer both sympathetic & Parasympathetic nervous system function
• Real time ECG Graphs on the software screen
• Automatic Blood pressure measurement
• Heart rate variability (HRV) analysis to find Autonomic balance
• The individual CAN test take as little as 15 to 18 minutes.
• Interpretive reports are generated immediately after testing.
• The reports are very easy to read and understand and include additional details and graph options for the physician.
• Bluetooth & USB computer interface
• Works with Windows 7/8/10 operating system
• LED Panel design for easy understanding of the test
• User friendly software
Technical Specifications:
ECG Recording: 3 Electrode method Test: series of 6 tests
Computer Interface Windows 7/8/10 Bluetooth & USB
Blood Pressure Method: Oscillometric Pressure
Range: 40-300 mmHg
Power Requirements Votage: 230V AC Frequency: 50Hz
Connect to Buy or Products Demo @ Your Place
wa.me/918960979714
Email ID [e-mail]
Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That?
www.hindawi.com/journals/jdr/...
Cardiac autonomic neuropathy (CAN) is a frequent but underdiagnosed complication of diabetes mellitus. It has a strong influence on various cardiac disorders including myocardial ischemia and infarction, hypertension, orthostatic hypotonia, heart failure, and arrhythmias. CAN can lead to severe morbidity and mortality and increase the risk of sudden cardiac death. Methods. This review article summarizes the latest evidence regarding the epidemiology, pathogenesis, influence on the cardiovascular system, and diagnostic methods for CAN. The methodology of this review involved analyzing available data from recent papers relevant to the topic of diabetic autonomic neuropathy and cardiac disorders. Conclusions. The early diagnosis of CAN can improve the prognosis and reduce adverse cardiac events. Methods based on heart rate variability enable the diagnosis of CAN even at a preclinical stage. These methods are simple and widely available for use in everyday clinical practice. According to the recently published Toronto Consensus Panel on Diabetic Neuropathy, all diabetic patients should be screened for CAN. Because diabetes mellitus often coexists with heart diseases and the most common methods used for diagnosis of CAN are based on ECG, not only diabetologists but also cardiologists should be responsible for diagnosis of CAN.
1. Introduction
Diabetes mellitus (DM) affects at least 8.5% of the global population, that is, about 422 million people worldwide [1]. Diabetes leads to complications in many parts of the body and can increase the overall risk of dying prematurely. Possible complications include heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage. It is difficult to estimate the actual prevalence of diabetic complications, because especially microvascular complications are often underdiagnosed. The incidence of cardiac or cerebrovascular disease is two to four times higher in diabetic patients than in the general population. The leading cause of mortality and morbidity in patients with DM is cardiovascular diseases (CVD), such as coronary artery disease (CAD). The influence of diabetes on CAD is synergistic with other factors, such as age, hypercholesterolemia, hypertension, and smoking. Therefore, most preventive strategies focus on improving glycemic control, lowering blood pressure, and treating dyslipidemia [2]. Despite that CVD remains the major cause of mortality and morbidity in patients with DM, the autonomic nervous system (ANS) has an important influence on CVD. Two parts of the ANS-parasympathetic (PNS) and sympathetic (SNS)-cooperate to control heart rate, cardiac output, myocardial contractility, and constriction and dilatation of blood vessels [3]. Cardiac autonomic neuropathy has a major impact on CVD in diabetes. CAN is a very common complication of DM and very often not diagnosed. Based on the Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy, CAN is defined as the impairment of cardiovascular autonomic control in patients with established DM following the exclusion of other causes.

[@funzoned5589]

What is the price of the machine?

[@kodysdiabeticfootcaremedic2436]

1.75 Lakh